SCHEMBL4661676

SCHEMBL4661676

CCOC(=O)CC(C(=O)OCC)=C1CC1.CCOC(=O)CC(C(=O)OCC)=C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
ALDH1A1 P00352 4/20 0.38
LMNA P02545 3/20 0.38
GRIK1 P39086 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2D6 P10635 1/20 0.35
NLRP3 Q96P20 3/20 0.35
PARP1 P09874 1/20 0.35
TRPA1 O75762 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
KDM4E B2RXH2 5/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 1/20 0.34
ALOX12 P18054 1/20 0.34
RECQL P46063 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048447 0.85 EGLN1 (0.41) MGAMGAASIMGAM2ALDH1A1
SCHEMBL27789732 0.79 GRIK1 (0.38) GAAALDH1A1LMNAGRIK1ALOX15
SCHEMBL28052037 0.77 FAAH (0.37) ALDH1A1LMNAGRIK1ALOX15KDM4E
SCHEMBL12640922 0.75 GRIK1 (0.40) MGAMGAASIMGAM2ALDH1A1
SCHEMBL6551852 0.75 GRIK1 (0.40) MGAMGAASIMGAM2ALDH1A1
SCHEMBL14598192 0.75 GRIK1 (0.40) MGAMGAASIMGAM2ALDH1A1
SCHEMBL3179017 0.74 MAPT (0.38) MGAMGAASIMGAM2ALDH1A1
SCHEMBL13269286 0.74 ALDH1A1 (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL7041913 0.73 GLO1 (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL13783789 0.73 MGAM (0.38) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392638-B1 PROCESS FOR PREPARING ALKYLIDENE SUBSTITUTED SUCCINIC ACID ESTERS BASELL POLIOLEFINE ITALIA SRL (IT) 2016-12-14 EP disclosed
EP-1527039-B1 PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES BASELL POLIOLEFINE SRL (IT) 2008-12-24 EP disclosed
US-7465821-B2 Process for preparing alkylidene-substituted-1, 4-dions derivatives BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2008-12-16 US disclosed
US-7399879-B2 Process for preparing alkylidene-substituted-1,4-dions derivatives BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2008-07-15 US disclosed
US-6914153-B2 Process for preparing alkylidene substituted succinic acid esters BASSELL POLIOLEFINE ITALIA S.P.A. (IT) 2005-07-05 US disclosed
US-20050113599-A1 Process for preparing alkylidene-substituted -1, 4-dions derivatives BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2005-05-26 US disclosed
EP-1527039-A1 PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES Basell Poliolefine Italia S.P.A. (IT) 2005-05-04 EP disclosed
EP-1527040-A1 PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES Basel Poliolefine Italia SpA (IT) 2005-05-04 EP disclosed
US-20050080290-A1 Process for preparing alkylidene-substituted-1, 4-dions derivatives BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2005-04-14 US disclosed
EP-1392638-A1 PROCESS FOR PREPARING ALKYLIDENE SUBSTITUTED SUCCINIC ACID ESTERS Basell Poliolefine Italia S.p.A. (IT) 2004-03-03 EP disclosed
WO-2004014838-A1 PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-02-19 WO disclosed
WO-2004014839-A1 PROCESS FOR PREPARING ALKYLIDENE-SUBSTITUTED-1,4-DIONS DERIVATIVES BASEL POLIOLEFINE ITALIA S.P.A. (IT) 2004-02-19 WO disclosed
US-20030181743-A1 Process for preparing alkylidene substituted succinic acid esters BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2003-09-25 US disclosed
WO-2002098837-A1 PROCESS FOR PREPARING ALKYLIDENE SUBSTITUTED SUCCINIC ACID ESTERS BASELL POLIOLEFINE ITALIA S.P.A (IT) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113599-A1 Process for preparing alkylidene-substituted -1, 4-dions derivatives KCNJ4, NR3C2, NR4A2 MGAM 3919/4885GAA 4586/4885SI 3511/4885
US-20030181743-A1 Process for preparing alkylidene substituted succinic acid esters OGDH, SCO2, SUCNR1 MGAM 776/4885GAA 3356/4885SI 32/4885
US-20050080290-A1 Process for preparing alkylidene-substituted-1, 4-dions derivatives RTN4, NR4A2, NR3C2 MGAM 4851/4885GAA 4844/4885SI 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.